December 16, 2008

Jerini Receives Request for Transfer of Minority Shareholders’ Shares in Jerini AG to Shire Deutschland Investments GmbH

October 10, 2008

Strategic Review of Jerini Assets Completed

July 15, 2008

Jerini Receives European Commission Approval for Firazyr® (Icatibant) in the Treatment of HAE

July 3, 2008

Jerini AG and Shire Announce Strategic Partnership

April 24, 2008

Jerini Receives Positive CHMP Opinion for European Approval of Icatibant in the Treatment of HAE

April 24, 2008

FDA Issues Not Approvable Letter for Icatibant in the Treatment of HAE
Jerini Expects CHMP Opinion for European Marketing Authorization Later Today